share_log

Stifel Maintains Buy on Disc Medicine, Raises Price Target to $73

Stifel Maintains Buy on Disc Medicine, Raises Price Target to $73

Stifel维持对Disc Medicine的买入,将目标股价上调至73美元
Moomoo 24/7 ·  04/08 08:44

Stifel analyst Benjamin Burnett maintains Disc Medicine (NASDAQ:IRON) with a Buy and raises the price target from $71 to $73.

Stifel分析师本杰明·伯内特维持Disc Medicine(纳斯达克股票代码:IRON)的买入并将目标股价从71美元上调至73美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发